Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001482981-25-000143
Filing Date
2025-08-21
Accepted
2025-08-21 16:04:52
Documents
1
Period of Report
2025-08-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5649
  Complete submission text file 0001482981-25-000143.txt   7100
Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
Ridloff Elena (Reporting) CIK: 0001772518 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42504 | Film No.: 251240729

Mailing Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451
Business Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451 617-819-2020
Sionna Therapeutics, Inc. (Issuer) CIK: 0002036042 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)